ClearPoint Neuro (CLPT)
(Delayed Data from NSDQ)
$5.33 USD
+0.07 (1.33%)
Updated Apr 29, 2024 04:00 PM ET
After-Market: $5.34 +0.01 (0.19%) 7:58 PM ET
3-Hold of 5 3
D Value B Growth B Momentum C VGM
Price, Consensus and EPS Surprise
CLPT 5.33 +0.07(1.33%)
Will CLPT be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for CLPT based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for CLPT
Why ClearPoint Neuro (CLPT) Stock Might be a Great Pick
ClearPoint Neuro, Inc. (CLPT) Reports Q4 Loss, Tops Revenue Estimates
CLPT: What are Zacks experts saying now?
Zacks Private Portfolio Services
ClearPoint's (CLPT) Prism System Favored by Latest Study
OrthoPediatrics (KIDS) Reports Q4 Loss, Tops Revenue Estimates
Integra LifeSciences (IART) Misses Q4 Earnings and Revenue Estimates
Other News for CLPT
ClearPoint Neuro Announces FDA Clearance of Prism Bone Anchor Accessory
ClearPoint Neuro announces FDA nod for its prism bone anchor accessory
ClearPoint Neuro announces FDA clearance of Prism Bone Anchor Accessory
Wall Street Analysts Are Bullish on Top Healthcare Picks
ClearPoint Neuro: Macro-Induced Multiple Compression